Abella et al. [1] suggests that pre-exposure Hydroxychloroquine prophylaxis might protect a person against COVID-19, but to acquire immunity against it! Continue reading Cool but Misinterpreted HCQ PreP Study
Fauci Lied about Cross-Reactivity Study
Dr. Anthony Fauci brazenly lied to Senator Rand Paul, MD, when questioned about preexisting immunity to COVID-19, that some people have from coronavirus common colds. Existence of such cross-reactivity was not in doubt and was acknowledged by Dr. Fauci earlier. But on Wednesday, September 23, Dr. Fauci said “there was a study that recently came out that preexisting immunity to coronaviruses that are common cold do not cross-react with the covid-19”. Continue reading Fauci Lied about Cross-Reactivity Study
NIH Scientists Receive Royalties from Big Pharma
Under 15 U.S. Code § 3710c, federal researchers, whose work was patented and commercialized, receive royalties at the rate of at least 15% of what the US government receives from the licensees, capped at $150,000 per person, per year. NIH and CDC pay their scientists 25% (on amounts over $50,000). These royalties are paid even after the person leaves the government employment and continue after his or her death.
NIH, NIAID, or CDC researcher who contributed to the development of a novel drug or therapy, and was named as one of the inventors on a commercialized patent, may be entitled to $3 million in royalties over the 20-year lifespan of the patent. Continue reading NIH Scientists Receive Royalties from Big Pharma
Remdesivir has only insignificant antiviral effect against SARS-COV-2 but dangerous adverse events
Update on 2020-10-30: the analysis of the Final Report of the NIAID study (Beigel et al. here) is published in “Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine. It amplifies the conclusions of this paper. This paper’s section devoted to Beigel et al. is obsoleted. Continue reading Remdesivir has only insignificant antiviral effect against SARS-COV-2 but dangerous adverse events
The Myth that HCQ Interferes with RDV
It is increasingly clear that on June 15, the FDA executed two coordinated attacks against Hydroxychloroquine (HCQ). One was the EUA revocation, supported by a junk science memo, and a press release saying “the FDA determined that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA” (emphasis is added). The Big Tech and MSM distorted this already incorrect determination by omitting the last clause.
But within hours of this press release, the FDA issued another attack with a scary title Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use. This “update” started with Continue reading The Myth that HCQ Interferes with RDV
Death Rates Rise after the FDA Memo
The following chart shows the weekly number of deaths from all causes in the US, from January 1 till August 15 (snapshot from September 2). There was an increase in deaths from all causes after the anti-HCQ FDA’s memo from June 15.
HCQ is Effective and Approved
Hydroxychloroquine (HCQ) is approved by the FDA as an antimalarial and anti-rheumatic medication and can be prescribed by doctors for any disease. Neither the issuance nor the revocation of the Emergency Use Authorization (EUA) for HCQ has any impact on its status as an approved drug available for prescriptions. The EUA was only needed to use HCQ from the Strategic National Stockpile. Continue reading HCQ is Effective and Approved
Yes, there is a cure for COVID-19
The world has a cure for COVID-19. The current COVID-19 mortality in all countries of the Northern Hemisphere, except for Israel, is 4-40 times lower than in the US. Israel stopped using Hydroxychloroquine, probably under the influence of the Big Tech misinformation.
Fig. 1. COVID-19 mortality in the US, Canada, Europe, Asia, Africa, China, and India. Deaths per Million, per day, averaged over 7 days.
